Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study

References

• Richters A, Aben KKH, Kiemeney LA. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–1904. doi:10.1007/s00345-019-02984-4
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics; surveillance research program. Available from: https://seer.cancer.gov/explorer/. Accessed February 28, 2022.
   Google Scholar
• Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13(1). doi:10.1186/s13045-020-00986-z
   Web of Science ®Google Scholar
• Sylvester RJ, Rodríguez O, Hernández V, et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel[Formula present]. Eur Urol. 2021;79(4):480–488. doi:10.1016/j.eururo.2020.12.033
   PubMed Web of Science ®Google Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2020. doi:10.1016/j.eururo.2020.03.055
   Web of Science ®Google Scholar
• Krajewski W, Zdrojowy R, Tupikowski K, Małkiewicz B, Kołodziej A. How to lower postoperative complications after radical cystectomy - a review. Cent Eur J Urol. 2016;69(4):370–376. doi:10.5173/CEJU.2016.880
   PubMedGoogle Scholar
• Porter MP, Gore JL, Wright JL. Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study. World J Urol. 2011;29(1):73–77. doi:10.1007/s00345-010-0626-3
   PubMed Web of Science ®Google Scholar
• Zhong J, Switchenko J, Jegadeesh NK, et al. Comparison of outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder preservation. Am J Clin Oncol Cancer Clin Trials. 2019;42(1):36–41. doi:10.1097/COC.0000000000000471
   PubMed Web of Science ®Google Scholar
• Giacalone NJ, Shipley WU, Clayman RH, et al. Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience. Eur Urol. 2017;71(6):952–960. doi:10.1016/j.eururo.2016.12.020
   PubMed Web of Science ®Google Scholar
• John JB, Varughese MA, Cooper N, et al. Treatment allocation and survival in patients diagnosed with nonmetastatic muscle-invasive bladder cancer: an analysis of a national patient cohort in England. Eur Urol Focus. 2021;7(2):359–365. doi:10.1016/J.EUF.2020.01.013
   PubMedGoogle Scholar
• Denton FT, Spencer BG. Some demographic consequences of revising the definition of “old age” to reflect future changes in life table probabilities. Can J Aging. 2002;21(3):349–356. doi:10.1017/S0714980800001677
   Web of Science ®Google Scholar
• Khan KT, Hemati K, Donovan AL. Geriatric physiology and the frailty syndrome. Anesthesiol Clin. 2019;37(3):453–474. doi:10.1016/j.anclin.2019.04.006
   PubMedGoogle Scholar
• Garg T, Young AJ, Kost KA, et al. Burden of multiple chronic conditions among patients with urological cancer. J Urol. 2018;199(2):543–550. doi:10.1016/J.JURO.2017.08.005
   PubMed Web of Science ®Google Scholar
• Elsayed AS, Aldhaam NA, Brownell J, et al. Perioperative and oncological outcomes of robot-assisted radical cystectomy in octogenarians. J Geriatr Oncol. 2020;11(4):727–730. doi:10.1016/J.JGO.2019.07.010
   PubMed Web of Science ®Google Scholar
• Xie S, Zhao Z, Feng B, et al. A comparative study of perioperative and survival outcomes of robot-assisted radical cystectomy in patients over 80 and under 80 years old. World J Surg Oncol. 2021;19(1):1–9. doi:10.1186/S12957-021-02312-4/TABLES/4
   PubMed Web of Science ®Google Scholar
• Froehner M, Koch R, Hübler M, et al. Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy. BMC Urol. 2018;18(1). doi:10.1186/S12894-018-0402-Z
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Living longer: is age 70 the new age 65? - Office for National Statistics. Office for National Statistics; 2019. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/livinglongerisage70thenewage65/2019-11-19. Accessed November 17, 2021.
   Google Scholar
• Karanikolos M, Adany R, McKee M. The epidemiological transition in Eastern and Western Europe: a historic natural experiment. Eur J Public Health. 2017;27(suppl_4):4–8. doi:10.1093/EURPUB/CKX158
   PubMed Web of Science ®Google Scholar
• Görgel SN, Şefik E, Balci U, Özer K, Girgin C, Dinçel Ç. The feasibility of radical cystectomy in elderly patients. Turk J Urol. 2014;40(1):9–14. doi:10.5152/TUD.2014.09735
   PubMedGoogle Scholar
• Pones M, D’andrea D, Mori K, et al. Differential prognosis and response of denovo vs. secondary muscle‐invasive bladder cancer: an updated systematic review and meta‐analysis. Cancers. 2021;13(10):2496. doi:10.3390/CANCERS13102496
   PubMed Web of Science ®Google Scholar
• Vlaming M, Kiemeney LA, van der Heijden AG. Survival after radical cystectomy: progressive versus De novo muscle invasive bladder cancer. Cancer Treat Res Commun. 2020;25:100264. doi:10.1016/J.CTARC.2020.100264
   PubMedGoogle Scholar
• Ge P, Wang L, Lu M, et al. Oncological outcome of primary and secondary muscle-invasive bladder cancer: a systematic review and meta-analysis. Sci Rep. 2018;8(1). doi:10.1038/S41598-018-26002-6
   Web of Science ®Google Scholar
• Pietzak EJ, Zabor EC, Bagrodia A, et al. Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy. Eur Urol. 2019;75(2):231–239. doi:10.1016/J.EURURO.2018.09.002
   PubMed Web of Science ®Google Scholar
• Bassett JC, Matulewicz RS, Kwan L, McCarthy WJ, Gore JL, Saigal CS. Prevalence and correlates of successful smoking cessation in bladder cancer survivors. Urology. 2021;153:236–243. doi:10.1016/j.urology.2020.12.033
   PubMed Web of Science ®Google Scholar
• Bjurlin MA, Goble SM, Hollowell CMP. Smoking cessation assistance for patients with bladder cancer: a National Survey of American Urologists. J Urol. 2010;184(5):1901–1906. doi:10.1016/J.JURO.2010.06.140
   PubMed Web of Science ®Google Scholar
• Sosnowski R, Przewoźniak K. The role of the urologist in smoking cessation: why is it important? Urol Oncol. 2015;33(1):30–39. doi:10.1016/J.UROLONC.2014.07.011
   PubMed Web of Science ®Google Scholar
• Westhoff E, Maria De Oliveira-neumayer J, Aben KK, Vrieling A, Kiemeney LA. Low awareness of risk factors among bladder cancer survivors: new evidence and a literature overview. Eur J Cancer. 2016;60:136–145. doi:10.1016/J.EJCA.2016.03.071
   PubMed Web of Science ®Google Scholar
• Burger M, Catto JWF, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–241. doi:10.1016/j.eururo.2012.07.033
   PubMed Web of Science ®Google Scholar
• Rushton L, Bagga S, Bevan R, et al. Occupation and cancer in Britain. Br J Cancer. 2010;102(9):1428–1437. doi:10.1038/sj.bjc.6605637
   PubMed Web of Science ®Google Scholar
• Hong H, Wang Q, Li J, Liu H, Meng X, Zhang H. Aging, cancer and immunity. J Cancer. 2019;10(13):3021–3027. doi:10.7150/JCA.30723
   PubMed Web of Science ®Google Scholar
• Kotfis K, Wittebole X, Jaschinski U, et al. A worldwide perspective of sepsis epidemiology and survival according to age: observational data from the ICON audit. J Crit Care. 2019;51:122–132. doi:10.1016/J.JCRC.2019.02.015
   PubMed Web of Science ®Google Scholar
• Abdollah F, Gandaglia G, Thuret R, et al. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol. 2013;37(3):219–225. doi:10.1016/j.canep.2013.02.002
   PubMed Web of Science ®Google Scholar
• Kessler ER, Kukreja JB, Geiger CL, Fischer SM. Treating elderly patients with muscle-invasive bladder cancer. J Natl Compr Cancer Netw. 2020;18(6):783–790. doi:10.6004/jnccn.2020.7585
   PubMed Web of Science ®Google Scholar
• Prout GR, Wesley MN, Yancik R, Ries LAG, Havlik RJ, Edwards BK. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer. 2005;104(8):1638–1647. doi:10.1002/cncr.21354
   PubMed Web of Science ®Google Scholar
• Lemiński A, Kaczmarek K, Bańcarz A, Zakrzewska A, Małkiewicz B, Słojewski M. Educational and psychological support combined with minimally invasive surgical technique reduces perioperative depression and anxiety in patients with bladder cancer undergoing radical cystectomy. Int J Environ Res Public Health. 2021;18(24):13071. doi:10.3390/ijerph182413071
   PubMed Web of Science ®Google Scholar
• Aldhaam NA, Elsayed AS, Hussein AA, et al. Impact of perioperative multidisciplinary rehabilitation pathway on early outcomes after robot-assisted radical cystectomy: a matched analysis. Urology. 2021;147:155–161. doi:10.1016/J.UROLOGY.2020.05.113
   PubMed Web of Science ®Google Scholar
• Hanna P, Zabell J, Osman Y, et al. Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients? World J Urol. 2021;39(6):1927–1933. doi:10.1007/S00345-020-03435-1
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Mallin K, Weaver MA, et al. Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base. BJU Int. 2014;114(1):46–55. doi:10.1111/bju.12566
   PubMed Web of Science ®Google Scholar
• Dybowski B. Competing risks of cystectomy – from calculator to decision. Cent Eur J Urol. 2017;70(1):128. doi:10.5173/CEJU.2016.943
   PubMed Web of Science ®Google Scholar
• Deuker M, Stolzenbach LF, Collà Ruvolo C, et al. Bladder cancer stage and mortality: urban vs. rural residency. Cancer Causes Control. 2021;32(2):139–145. doi:10.1007/s10552-020-01366-1
   PubMed Web of Science ®Google Scholar
• Hashibe M, Kirchhoff AC, Kepka D, et al. Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah. Cancer Med. 2018;7(4):1490–1497. doi:10.1002/cam4.1382
   PubMed Web of Science ®Google Scholar
• Guancial EA, Roussel B, Bergsma DP, et al. Bladder cancer in the elderly patient: challenges and solutions. Clin Interv Aging. 2015;10:939–949. doi:10.2147/CIA.S74322
   PubMed Web of Science ®Google Scholar